Helen C. Smith-Flick
Salisbury, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
Journal: Infection and immunity
Published: January 30, 2024
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
Journal: PloS one
Published: August 11, 2023
Predatory bacteria can protect SKH-1 mice from a lethal plague challenge.
Journal: Scientific reports
Published: January 11, 2019
Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
Journal: International journal of antimicrobial agents
Published: January 08, 2019
Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
Journal: PloS one
Published: February 19, 2018
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.
Journal: Antimicrobial agents and chemotherapy
Published: July 20, 2016
The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents.
Journal: Journal of immunology research
Published: April 15, 2014
The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.
Journal: Protein and peptide letters
Published: April 24, 2013
A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague.
Journal: Microbiology (Reading, England)
Published: March 10, 2012
Last Updated: 09/26/2026